Health ❯ Healthcare ❯ Obesity ❯ Treatment Options

Oral Medications

Wegovy Pill Fuels Massive Private Demand in UK as Supply Questions Grow

High preorders point to broader patient uptake with a real risk that manufacturing may not keep pace.

MHRA Approves Wegovy Daily Pill for Weight Loss in UK

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

Anvisa Expands Wegovy and Ozempic Uses to Cardiovascular and Kidney Protection

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

FDA Approves First Oral Wegovy Weight-Loss Pill as U.S. Availability Begins

FDA-Cleared Wegovy Pill Becomes First Oral GLP-1 for Weight Loss

FDA Approves First Oral Weight-Loss GLP-1: Wegovy Pill to Launch in January

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

Oral GLP-1 Pill Orforglipron Delivers Phase III Weight Loss as Obesity Care Broadens Beyond Injections

UK Weight-Loss Drug Access Squeezed by Mounjaro Price Hike as Lilly Points to 2026 Pill

Eli Lilly’s Oral Obesity Pill Triggers Stock Slide After Modest Weight-Loss Results